DK0804437T3 - [a]-Annelerede pyrrolderivater og deres anvendelse i farmacien - Google Patents
[a]-Annelerede pyrrolderivater og deres anvendelse i farmacienInfo
- Publication number
- DK0804437T3 DK0804437T3 DK95921800T DK95921800T DK0804437T3 DK 0804437 T3 DK0804437 T3 DK 0804437T3 DK 95921800 T DK95921800 T DK 95921800T DK 95921800 T DK95921800 T DK 95921800T DK 0804437 T3 DK0804437 T3 DK 0804437T3
- Authority
- DK
- Denmark
- Prior art keywords
- pct
- assolved
- pharmacy
- pyrrole derivatives
- sec
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4419315A DE4419315A1 (de) | 1994-06-01 | 1994-06-01 | Heteropyrrolizinverbindungen und deren Anwendung in der Pharmazie |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0804437T3 true DK0804437T3 (da) | 2005-11-14 |
Family
ID=6519632
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK95921800T DK0804437T3 (da) | 1994-06-01 | 1995-05-31 | [a]-Annelerede pyrrolderivater og deres anvendelse i farmacien |
Country Status (13)
Country | Link |
---|---|
US (1) | US5939415A (da) |
EP (1) | EP0804437B1 (da) |
JP (1) | JP3569823B2 (da) |
KR (1) | KR100378882B1 (da) |
AT (1) | ATE304543T1 (da) |
AU (1) | AU2672995A (da) |
CA (1) | CA2191745A1 (da) |
DE (2) | DE4419315A1 (da) |
DK (1) | DK0804437T3 (da) |
ES (1) | ES2248798T3 (da) |
FI (1) | FI113966B (da) |
NO (1) | NO311222B1 (da) |
WO (1) | WO1995032971A1 (da) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2181162T3 (es) | 1997-01-22 | 2003-02-16 | Ciba Sc Holding Ag | Bases fotoactivables que contienen nitrogeno, basadas en alfa-amino-cetonas. |
ES2291577T3 (es) | 1999-11-23 | 2008-03-01 | Merckle Gmbh | Derivados oxo e hidroxi de pirrolizinas antiinflamatorios y su aplicacion en farmacia. |
DE10001166A1 (de) * | 2000-01-13 | 2001-07-19 | Merckle Gmbh | Anellierte Pyrrolverbindungen, diese enthaltende pharmazeutische Mittel und deren Verwendung |
SK286608B6 (sk) * | 2000-01-28 | 2009-02-05 | Merckle Gmbh | Spôsob prípravy kyseliny 6-(4-chlórfenyl)-2,2-dimetyl-7-fenyl- 2,3-dihydro-1H-pyrolizin-5-yl octovej |
DE10004157A1 (de) | 2000-02-01 | 2001-08-02 | Merckle Gmbh Chem Pharm Fabrik | 4-Pyridyl-und 2,4-Pyrimidinyl-substituierte Pyrrolderivate und ihre Anwendung in der Pharmazie |
DE10141285A1 (de) | 2001-08-23 | 2003-03-27 | Merckle Gmbh | Verfahren zur Herstellung von 6-(4-Chlorphenyl)-2,2-dimethyl-7-phnyl-2,3-dihydro-1H-pyrrolizin-5-yl-essigsäure |
MXPA04001868A (es) | 2001-08-30 | 2005-10-05 | Merckle Gmbh | Uso de compuestos de pirrol anillados en el tratamiento de la degeneracion del hueso sub-condrial o cartilago articular. |
US6953787B2 (en) | 2002-04-12 | 2005-10-11 | Arena Pharmaceuticals, Inc. | 5HT2C receptor modulators |
JP4920409B2 (ja) | 2003-06-17 | 2012-04-18 | アリーナ ファーマシューティカルズ, インコーポレイテッド | 3−ベンズアゼピンを調製する方法 |
CN1805938B (zh) * | 2003-06-17 | 2010-06-16 | 艾尼纳制药公司 | 用于治疗5ht2c受体相关疾病的苯并氮杂卓衍生物 |
WO2005042490A1 (en) * | 2003-10-22 | 2005-05-12 | Arena Pharmaceuticals, Inc. | Benzazepine derivatives and methods of prophylaxis or treatment of 5ht2c receptor associated diseases |
WO2005042491A1 (en) * | 2003-10-22 | 2005-05-12 | Arena Pharmaceuticals, Inc. | Benzazepine derivatives and methods of prophylaxis or treatment of 5ht2c receptor associated diseases |
EA201200954A1 (ru) | 2004-12-21 | 2013-05-30 | Арена Фармасьютикалз, Инк. | Способ получения полугидрата гидрохлорида (r)-8-хлор-1-метил-2,3,4,5-тетрагидро-1н-3-бензазепина, фармацевтическая композиция на его основе и его применение |
EA015012B1 (ru) * | 2004-12-23 | 2011-04-29 | Арена Фармасьютикалз, Инк. | Композиция, содержащая фентермин и избирательный агонист рецептора 5ht, и ее применение |
DE102005012971A1 (de) | 2005-03-21 | 2006-09-28 | Merckle Gmbh | Polymorphe Form von 6-(4-Chlorphenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1H-pyrrolizin-5-yl-essigsäure |
US8168782B2 (en) | 2006-04-03 | 2012-05-01 | Arena Pharmaceuticals, Inc. | Processes for the preparation of 8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine and intermediates related thereto |
US8299241B2 (en) * | 2006-12-05 | 2012-10-30 | Arena Pharmaceuticals, Inc. | Processes for preparing (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine and intermediates thereof |
WO2009111004A1 (en) * | 2008-03-04 | 2009-09-11 | Arena Pharmaceuticals, Inc. | Processes for the preparation of intermediates related to the 5-ht2c agonist (r)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine |
US8952197B2 (en) | 2009-06-18 | 2015-02-10 | Arena Pharmaceuticals, Inc. | Processes for the preparation of 5-HT2C receptor agonists |
KR20130112848A (ko) | 2010-06-02 | 2013-10-14 | 아레나 파마슈티칼스, 인크. | 5-ht2c 수용체 아고니스트의 제조 방법 |
SG10201506865WA (en) | 2010-09-01 | 2015-10-29 | Arena Pharm Inc | Non-hygroscopic salts of 5-ht2c agonists |
CN107669687A (zh) | 2010-09-01 | 2018-02-09 | 艾尼纳制药公司 | 用于体重控制的5‑ht2c激动剂的调节释放剂型 |
US9248133B2 (en) | 2010-09-01 | 2016-02-02 | Arena Pharmaceuticals, Inc. | Salts of lorcaserin with optically active acids |
SG10201506896RA (en) | 2010-09-01 | 2015-10-29 | Arena Pharm Inc | Administration of lorcaserin to individuals with renal impairment |
AR088670A1 (es) | 2012-10-09 | 2014-06-25 | Arena Pharm Inc | Metodo de control del peso |
KR20150143104A (ko) | 2014-06-13 | 2015-12-23 | 이경희 | 원적외선을 이용한 건식 발 온열기 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SU417424A1 (da) * | 1972-02-03 | 1974-02-28 | ||
GB1461592A (en) * | 1973-04-25 | 1977-01-13 | Agfa Gevaert | Specially sensitized direct positive silver halide emulsions |
US3920672A (en) * | 1974-08-22 | 1975-11-18 | Syntex Inc | Thiacycl (2.2.2.)azine carboxylic acids |
US4536512A (en) * | 1982-10-08 | 1985-08-20 | Merck & Co., Inc. | 5-(2,3-Dihydro-1H-pyrrolizin-5-oyl)-2,3-dihydro-1H-pyrrolizine-1-alkanoic or carboxylic acids and use thereof as anti-inflammatory and analgesic agents |
MA20003A1 (fr) * | 1983-01-13 | 1984-10-01 | Rhone Poulenc Sante | Nouveaux derives de pyrrole orthocondense utiles pour la preparation de nouveaux produits et leurs preparation |
FR2557111B1 (fr) * | 1983-12-21 | 1986-04-11 | Rhone Poulenc Sante | Nouveaux derives ortho-condenses du pyrrole, leur preparation et les medicaments qui les contiennent |
US5260451A (en) * | 1989-05-11 | 1993-11-09 | Merckle Gmbh | Substituted pyrrole compounds and use thereof in pharmaceutical compositions |
DE3915450A1 (de) * | 1989-05-11 | 1990-11-15 | Gerd Prof Dr Dannhardt | Substituierte pyrrolverbindungen und deren anwendung in der pharmazie |
DE69419327D1 (de) * | 1993-01-21 | 1999-08-12 | Konishiroku Photo Ind | Ein farbphotographisches Silberhalogenidmaterial |
US5552422A (en) * | 1995-01-11 | 1996-09-03 | Merck Frosst Canada, Inc. | Aryl substituted 5,5 fused aromatic nitrogen compounds as anti-inflammatory agents |
-
1994
- 1994-06-01 DE DE4419315A patent/DE4419315A1/de not_active Withdrawn
-
1995
- 1995-05-31 DK DK95921800T patent/DK0804437T3/da active
- 1995-05-31 EP EP95921800A patent/EP0804437B1/de not_active Expired - Lifetime
- 1995-05-31 AT AT95921800T patent/ATE304543T1/de not_active IP Right Cessation
- 1995-05-31 JP JP50033396A patent/JP3569823B2/ja not_active Expired - Fee Related
- 1995-05-31 AU AU26729/95A patent/AU2672995A/en not_active Abandoned
- 1995-05-31 ES ES95921800T patent/ES2248798T3/es not_active Expired - Lifetime
- 1995-05-31 WO PCT/EP1995/002078 patent/WO1995032971A1/de active IP Right Grant
- 1995-05-31 CA CA002191745A patent/CA2191745A1/en not_active Abandoned
- 1995-05-31 US US08/737,920 patent/US5939415A/en not_active Expired - Fee Related
- 1995-05-31 KR KR1019960706837A patent/KR100378882B1/ko not_active IP Right Cessation
- 1995-05-31 DE DE59511017T patent/DE59511017D1/de not_active Expired - Fee Related
-
1996
- 1996-11-29 FI FI964772A patent/FI113966B/fi active
- 1996-11-29 NO NO19965094A patent/NO311222B1/no unknown
Also Published As
Publication number | Publication date |
---|---|
DE4419315A1 (de) | 1995-12-07 |
ATE304543T1 (de) | 2005-09-15 |
ES2248798T3 (es) | 2006-03-16 |
NO965094D0 (no) | 1996-11-29 |
FI113966B (fi) | 2004-07-15 |
JPH10506369A (ja) | 1998-06-23 |
EP0804437B1 (de) | 2005-09-14 |
WO1995032971A1 (de) | 1995-12-07 |
AU2672995A (en) | 1995-12-21 |
NO965094L (no) | 1996-12-11 |
NO311222B1 (no) | 2001-10-29 |
FI964772A0 (fi) | 1996-11-29 |
US5939415A (en) | 1999-08-17 |
FI964772A (fi) | 1997-01-27 |
EP0804437A1 (de) | 1997-11-05 |
JP3569823B2 (ja) | 2004-09-29 |
KR100378882B1 (ko) | 2003-08-02 |
DE59511017D1 (de) | 2005-10-20 |
CA2191745A1 (en) | 1995-12-07 |
KR970703345A (ko) | 1997-07-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0804437T3 (da) | [a]-Annelerede pyrrolderivater og deres anvendelse i farmacien | |
DK0763037T3 (da) | [a]-Annellerede pyrrolderivater og deres anvendelse i farmacien | |
NO952132L (no) | Farmakologiske aktive pyridin-derivater og deres fremstilling | |
DK0763036T3 (da) | [a]-Annelerede pyrrolderivater og deres anvendelse i farmacien | |
NO306346B1 (no) | N-substituerte azabicykloalkanderivater, anvendelse derav og farmasöytisk preparat | |
LU91751I2 (fr) | Asenapin et ses dérivés pharmaceutiquement acceptables (SYCREST®) | |
KR960701051A (ko) | 이미다조피리딘 및 이를 위장 질환의 치료에 사용하는 방법(imidazopyridines and their use in treating castrointestinal diseases) | |
DK0782567T3 (da) | Isothiourinstofderivater og fremgangsmåder til deres fremstilling | |
NO306400B1 (no) | N-substituerte azabicykloheptan-derivater, anvendelse derav og farmasöytisk preparat | |
NO954316D0 (no) | Benzo(f)kinoksalidinonderivater, deres fremstilling og anvendelse i legemidler | |
DK0766695T3 (da) | Pyrrolidinderivater til behandling af CCK- og gastrinrelaterede sygdomme | |
ATE145135T1 (de) | Verwendung von riluzol zum schutz gegen strahlenschäden |